Twist Bioscience Corporation Common Stock TWST
$188.67
+0.33%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (8 Buy · 2 Hold · 1 Sell)
- Average Price Target
- $115.27
- Implied Upside
- -38.9%
- Price Target Range
- $41.00 – $212.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-01 | GuggenheimSubbu Nambi |
Maintains | Buy | $107 → $212 |
| 2026-09-29 | Leerink PartnersPuneet Souda |
Maintains | Outperform | $160 → $190 |
| 2026-09-18 | BWS FinancialHamed Khorsand |
Maintains | Sell | $45 |
| 2026-09-17 | Leerink PartnersPuneet Souda |
Maintains | Outperform | $120 → $160 |
| 2026-09-09 | BWS FinancialHamed Khorsand |
Initiates coverage on | Sell | $45 |
| 2026-09-09 | UBSDoug Schenkel |
Initiates coverage on | Neutral | $144 |
| 2026-08-05 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $85 → $115 |
| 2026-08-04 | BairdCatherine Ramsey |
Maintains | Outperform | $113 → $115 |
| 2026-07-14 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $90 → $120 |
| 2026-07-06 | Evercore ISI GroupVijay Kumar |
Downgrades | Outperform → In-line | $66 → $102 |
| 2026-06-29 | GuggenheimSubbu Nambi |
Maintains | Buy | $60 → $107 |
| 2026-06-24 | BarclaysLuke Sergott |
Maintains | Overweight | $65 → $95 |
| 2026-06-15 | TD CowenBrendan Smith |
Maintains | Buy | $68 → $89 |
| 2026-06-15 | Canaccord GenuityKyle Mikson |
Initiates coverage on | Buy | $90 |
| 2026-06-11 | Piper SandlerDavid Westenberg |
Initiates coverage on | Overweight | $85 |
| 2026-05-05 | Leerink PartnersPuneet Souda |
Upgrades | Market perform → Outperform | $70 |
| 2026-05-05 | BarclaysLuke Sergott |
Maintains | Overweight | $55 → $65 |
| 2026-05-05 | GuggenheimSubbu Nambi |
Maintains | Buy | $55 → $60 |
| 2026-05-05 | BairdCatherine Ramsey |
Maintains | Outperform | $50 → $65 |
| 2026-04-14 | BarclaysLuke Sergott |
Maintains | Overweight | $50 → $55 |
| 2026-04-06 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $52 → $56 |
| 2026-03-30 | GuggenheimSubbu Nambi |
Maintains | Buy | $50 → $55 |
| 2026-02-03 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $42 → $52 |
| 2026-02-03 | BarclaysLuke Sergott |
Maintains | Overweight | $39 → $50 |
| 2026-01-26 | GuggenheimSubbu Nambi |
Maintains | Buy | $77 → $79 |
| 2026-01-08 | TD CowenBrendan Smith |
Maintains | Buy | $32 → $43 |
| 2025-12-15 | BarclaysLuke Sergott |
Maintains | Overweight | $37 → $39 |
| 2025-11-17 | BarclaysLuke Sergott |
Maintains | Overweight | $40 → $37 |
| 2025-11-04 | Stephens & Co.Steven Etoch |
Initiates coverage on | Overweight | $41 |
| 2025-10-07 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $46 → $42 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $188.67
- Market Cap
- $12.51 billion
- 52-Week Range
- $23.30 – $200.31
- Average Volume
- 2.06 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.